scholarly journals Wing tags severely impair movement in African Cape Vultures

2021 ◽  
Vol 9 (1) ◽  
Author(s):  
Teja Curk ◽  
Martina Scacco ◽  
Kamran Safi ◽  
Martin Wikelski ◽  
Wolfgang Fiedler ◽  
...  
Keyword(s):  
Adverse Effects ◽  
Animal Movement ◽  
Flight Performance ◽  
Flight Behaviour ◽  
Observed Behaviour ◽  
Scientific Results ◽  
The Impact ◽  
Tagging Methods ◽  
Study Species

Abstract Background The use of tracking technologies is key for the study of animal movement and pivotal to ecological and conservation research. However, the potential effects of devices attached to animals are sometimes neglected. The impact of tagging not only rises welfare concerns, but can also bias the data collected, causing misinterpretation of the observed behaviour which invalidates the comparability of information across individuals and populations. Patagial (wing) tags have been extensively used as a marking method for visual resightings in endangered vulture species, but their effect on the aerodynamics of the birds and their flight behaviour is yet to be investigated. Using GPS backpack mounted devices, we compared the flight performance of 27 captive and wild Cape Vultures (Gyps coprotheres), marked with either patagial tags or coloured leg bands. Results Individuals equipped with patagial tags were less likely to fly, travelled shorter distances and flew slower compared to individuals equipped with leg bands. These effects were also observed in one individual that recovered its flight performance after replacing its patagial tag by a leg band. Conclusions Although we did not measure the effects of patagial tags on body condition or survival, our study strongly suggests that they have severe adverse effects on vultures’ flight behaviour and emphasises the importance of investigating the effects that tagging methods can have on the behaviour and conservation of the study species, as well as on the quality of the scientific results.

scholarly journals Wing tags severely impair movement in African Cape Vultures

2020 ◽  
Author(s):  
Teja Curk ◽  
Martina Scacco ◽  
Kamran Safi ◽  
Martin Wikelski ◽  
Wolfgang Fiedler ◽  
...  
Keyword(s):  
Adverse Effects ◽  
Animal Movement ◽  
Flight Performance ◽  
Flight Behaviour ◽  
Observed Behaviour ◽  
Scientific Results ◽  
The Impact ◽  
Tagging Methods ◽  
Study Species

AbstractBackgroundThe use of tracking technologies is key for the study of animal movement and pivotal to ecological and conservation research. However, the potential effects of devices attached to animals are sometimes neglected. The impact of tagging not only rises welfare concerns, but can also bias the data collected, causing misinterpretation of the observed behaviour which invalidates the comparability of information across individuals and populations. Patagial (wing) tags have been extensively used as a marking method for visual resightings in endangered vulture species, but their effect on the aerodynamics of the birds and their flight behaviour is yet to be investigated. Using GPS backpack mounted devices, we compared the flight performance of 27 captive and wild Cape Vultures (Gyps coprotheres), marked with either patagial tags or coloured leg bands.ResultsIndividuals equipped with patagial tags were less likely to fly, travelled shorter distances and flew slower compared to individuals equipped with leg bands. These effects were also observed in one individual that recovered its flight performance after replacing its patagial tag by a leg band.ConclusionsAlthough we did not measure the effects of patagial tags on body condition or survival, our study strongly suggests that they have severe adverse effects on vultures’ flight behaviour and emphasises the importance of investigating the effects that tagging methods can have on the behaviour and conservation of the study species, as well as on the quality of the scientific results.

Sexual Dysfunction in Patients with Neuropsychiatric Disorders: Challenges and Opportunities

CNS Spectrums ◽  
2006 ◽  
Vol 11 (S9) ◽  
pp. 4-4
Author(s):  
Barry Gidal ◽  
John J. Barry
Keyword(s):  
Quality Of Life ◽  
Sexual Dysfunction ◽  
Adverse Effects ◽  
Sexual Function ◽  
Healthcare Providers ◽  
Well Being ◽  
Sexual Disorders ◽  
Functional Impairments ◽  
The Impact

Quality-of-life issues in healthcare have come to be of paramount importance for a population that increasingly expects healthcare not only to treat major illnesses but also to optimize normal levels of physical and psychosocial functioning and overall well-being. Healthcare providers have also increasingly appreciated the impact that adverse effects of treatment can have on quality of life, as well as on compliance with and the effectiveness of treatment.Many functional impairments and adverse treatment effects take the form of clinical complaints that patients and caregivers typically report to their healthcare providers without prompting. Other adverse effects are not so obviously clinical or treatment-related, and patients may not be inclined or may even be reluctant to bring them up when talking with the provider. Impairment of sexual function is a problem of this kind.Sexual dysfunction appears to be common and frequently underrecognized in certain patient populations. For example, it has been estimated that 25% to 63% of women and 10% to 52% of men with epilepsy have some form of sexual dysfunction, yet in clinical reviews of sexual disorders, epilepsy is not listed as one of the medical conditions commonly associated with impaired sexual function.

scholarly journals Gender disparity among renal transplant recipients receiving immunosuppressive therapy

2021 ◽  
Vol 11 (5) ◽  
pp. 68
Author(s):  
Mervat Mamdouh Abu Zead ◽  
Lamia Mohamed Nabil Ismail ◽  
Sahier Omar El-khashab
Keyword(s):  
Quality Of Life ◽  
Renal Transplant ◽  
Adverse Effects ◽  
Gender Disparity ◽  
Renal Transplant Recipients ◽  
Transplant Recipients ◽  
Term Survival ◽  
Medication Schedule ◽  
The Impact

Immunosuppressant therapies are considered vital for the long-term survival of kidney grafts, however it can significantly modify patients’ HRQOL because of their adverse effects and the complex medication schedule they represent. Aims: (1) To explore symptom experiences and symptom distress with adverse effects of immunosuppressive therapies, (2) To assess the impact of symptoms experience and symptoms distress on health-related quality of life among renal transplant recipient, and (3) To correlate them with gender. One hundred Renal transplant recipients were interviewed using the End-Stage Renal Disease Symptom Checklist Transplantation Module (ESRDSCL-TM). Results: Most of the renal transplant participants reported best and good quality of life, however, there were a statistically significant differences by gender. Women reported low satisfaction in quality of life comparing with men. In relation to the most frequent distressing symptoms in men and women, the study revealed that women reported higher levels in majority of the given symptoms distress such as back pain, increased hair growth and mood swings. Moreover, women perceived higher means levels with respect to increased appetite while men reported more distress for the items as increased appetite, mood swings, decreased interest in sex, depression, and sleeplessness. Conclusion: Renal transplant recipients had good quality of life with immunosuppressive therapies, but intensive assessment of patients after transplantation should be done to identify their needs. Moreover, consideration should be taken with regards gender variations thus help planning to get better quality of life, as a relatively normal lifestyle is re-established.

scholarly journals Endocrinology trial design: adverse event reporting in randomised controlled trials of recombinant human GH in GH-deficient adults

2002 ◽  
Vol 175 (2) ◽  
pp. 545-552 ◽  
Author(s):  
J Bryant ◽  
E Loveman ◽  
C Cave ◽  
D Chase ◽  
R Milne
Keyword(s):  
Quality Of Life ◽  
Adverse Event ◽  
Adverse Effects ◽  
Adverse Events ◽  
Randomised Controlled Trials ◽  
Controlled Trials ◽  
Number Of Patients ◽  
Randomised Controlled ◽  
The Impact

We have evaluated the reporting of withdrawals due to adverse effects and specific adverse effects in randomised controlled trials of recombinant human GH in adults. A systematic review was carried out of randomised controlled trials of the clinical effectiveness of recombinant human GH in adults with GH deficiency in relation to impact on quality of life. Trials were identified from searching electronic databases, bibliographies of related articles and consulting experts. There was reporting of withdrawals due to adverse effects and specific adverse effects. Rates of oedema and arthralgia were reported in included trials. Seventeen randomised controlled trials, published between 1990 and 1999, met the inclusion criteria for the review. Nine trials reported data on the effectiveness of GH on quality of life in adults. Only five trials (29%) reported both withdrawals from the study because of adverse events and specific adverse events with numbers per study arm and per type. Six further trials (35%) reported either withdrawal details or specific adverse event details or partial data on specific adverse events. Six trials (35%), however, did not report information on either withdrawals or specific adverse events. Ten of the 17 studies (59%) reported the number of patients who withdrew from the study due to adverse events per study arm and type of adverse event per study arm. Seven of the 17 trials (41%) reported the number of specific adverse events per study arm and six (35%) reported the type per study arm. The reporting of adverse events in randomised controlled trials of GH is variable and not consistent across trials. It is not possible to assess the impact that adverse events may have had on unblinding patients, and therefore the extent to which the effects of GH may have been overestimated. Therefore those conducting endocrinology trials in the future need to pay attention to the reporting of withdrawals due to adverse events and specific adverse events.

Quality of life after morphine treatment in patients with advanced and terminal cancer.

2017 ◽  
Vol 35 (8_suppl) ◽  
pp. 54-54
Author(s):  
Tammy Alonso
Keyword(s):  
Quality Of Life ◽  
Palliative Care ◽  
Adverse Effects ◽  
Life Quality ◽  
Palliative Care Unit ◽  
Stage Iii ◽  
Oncological Patients ◽  
Morphine Administration ◽  
The Impact

54 Background: Life quality evaluation is the main indicator of the impact of palliative care, which has the objective of diminished suffering. It includes symptoms control and the satisfactions of patients and relatives. Opioids constitute a milestone in pain treatment. Present work is aimed to evaluate the secondary effects in oncological patients with bad prognosis treated with morphine at the Palliative Care Unit (PCU) of the National institute of Oncology and Radiobiology. Methods: The sample includes 72 cancer patients that arrive to the Palliative Care Unit of the National Institute of Oncology and Radiobiology of Cuba, from May 2015 to May 2016. It was characterized in terms of the demographic and clinical parameters. Severity of symptoms was evaluated using the Visual Analogue Scale (VAS). Pain was evaluated using Analogue Visual Scale. Morphine was administered subcutaneously. Incidence of adverse effects related to morphine administration and accuracy of moderate to severe pain was measured. Results: The age range was from 41 to 50 and females predominate. Gynecological cancers were the most frequent pathology. Most frequent adverse effects related to morphine administration were: constipation (35%), nauseas and vomiting (25%) and somnolence (22%). Despite of morphine myths that terrify many physicians and make them use this drug at the end of analgesic scale, in the present work was used in patients in clinical stage III (58.6 % of the 63.8 % survivors) with an effective pain control. Life quality, that includes mood, functional capacity, social interaction and recurrent symptoms, was improved. Conclusions: The use of morphine for pain relief in stage III oncological patients increases the quality of life of patients and relatives for a longer period of time.

Quality of Life in Patients with Schizophrenia: The Impact of Socio-economic Factors and Adverse Effects of Atypical Antipsychotics Drugs

2014 ◽  
Vol 85 (3) ◽  
pp. 357-367 ◽  
Author(s):  
Aurigena Antunes de Araújo ◽  
Diego de Araújo Dantas ◽  
Gemma Galgani do Nascimento ◽  
Susana Barbosa Ribeiro ◽  
Katarina Melo Chaves ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Adverse Effects ◽  
Atypical Antipsychotics ◽  
Economic Factors ◽  
The Impact ◽  
Socio Economic Factors

Impact of adverse effects to oral antidiabetics on adherence and quality of life in patients with type 2 diabetes

2020 ◽  
Vol 30 (Supplement_2) ◽  
Author(s):  
C Almeida ◽  
C Rocha ◽  
R Cruz
Keyword(s):  
Quality Of Life ◽  
Type 2 Diabetes ◽  
Adverse Effects ◽  
Adverse Events ◽  
Negative Impact ◽  
Therapeutic Regime ◽  
The Impact ◽  
Adherence To Therapy

Abstract Introduction Diabetes is a metabolic disorder with many comorbidities, microvascular and macrovascular complications. In Portugal the prevalence was 13,3% which corresponds to 1 million Portuguese diagnosed, but the forecasts are for a big increase. The various therapeutic options currently available have been shown to be effective in controlling glycaemia and HbA1 levels. Adherence with this therapeutic is essential for optimization and control of chronic conditions. However, they present side effects that may compromise adherence to therapy and the quality of life of the patients. Objectives The objective of this study is to evaluate the impact of the adverse effects of oral antidiabetic medicines on patient’s quality of life and adherence to therapy. Methodology We developed a cross-sectional study in a sample of 65 patients with type 2 diabetes recruited in several Portuguese pharmacies. Data collected through a questionnaire previously validated with MAT Scale and EQ-5D-3L questionnaire. Results In total, 36 men (55,4%) and 29 women (44,6%) participated in the study, the mean age was 65 years. 73,8 % take oral medication and 92,30% of people have high adherence. The adverse events with more impact in the patients’ perception are "Discomfort in the genital area", "Dry mouth" and gastrointestinal events such as "Abdominal distention", "Flatulence" and "Constipation". The number of adverse events have a negative impact on patients’ quality of life (rs=-0,479; p≤0,01). The satisfaction with the therapeutic regime is significantly associated with adherence (rs = 0,348; p≤0,01)and their quality of life (rs = 0,316; p=0,01). Conclusion We concluded that the adverse events have a negative impact on adherence and quality of life. The presence of adverse events, the type of medication and the therapeutic regimen are factors that negatively influence the patients’ quality of life, especially in the polymedicated elderly people.

scholarly journals The debate regarding maintenance treatment with antipsychotic drugs in schizophrenia

2018 ◽  
Vol 20 (3) ◽  
pp. 215-221 ◽  
Keyword(s):  
Adverse Effects ◽  
Maintenance Treatment ◽  
Treatment Guidelines ◽  
Chronic Schizophrenia ◽  
Intermittent Therapy ◽  
Open Label ◽  
Symptomatic Remission ◽  
Meta Analyses ◽  
The Impact

Several large meta-analyses of maintenance trials have confirmed that patients who suffer from chronic schizophrenia, randomized to placebo, are likely to experience earlier symptomatic worsening than patients randomized to a dopamine (DA)-blocking drug. These findings led expert groups to issue treatment guidelines, which recommend treatment with DA-blocking drugs for periods ranging from several years to indefinitely. The recommendations were accepted by the majority of, but not all, the experts, some of whom proposed a targeted or intermittent therapy approach by which DA-blocking drugs are discontinued upon symptomatic remission, to be renewed in case of symptom re-emergence. The debate between continued and targeted treatment approaches arises from disagreements regarding scientific and ethical questions. Scientifically, the discussion focuses on the quality and interpretation of the supporting or detracting evidence regarding each treatment option. For example, what is the percentage of individuals who can maintain stability off drugs? What is the rate of individuals who exacerbate despite maintenance treatment? What is the percentage of individuals who experience drug-related adverse effects? How can we interpret results of open-label, nonrandomized targeted trials? Regarding ethical questions, the debating sides disagree on how to weigh the impact of the decreased risk for exacerbation versus the certainty of adverse effects on the patients quality of life, and how to reach a patient-therapist shared decision within the constraints of mental illness.

scholarly journals The impact of medical therapy for benign prostatic obstruction on the health-related quality of life at tertiary hospital: A prospective study

2020 ◽  
Vol 8 (3) ◽  
pp. 091-096
Author(s):  
Henry Godfrey Kibona ◽  
Obadia Venance Nyongole ◽  
Njiku Marko Kimu
Keyword(s):  
Quality Of Life ◽  
Adverse Effects ◽  
Medical Therapy ◽  
Health Related Quality ◽  
Benign Prostatic Obstruction ◽  
Quality Life ◽  
Related Quality ◽  
Health Related ◽  
The Impact

Benign prostatic obstruction (BPO) is a common condition in older men that often result in lower urinary tract symptoms (LUTS). LUTS associated with Benign Prostate Enlargement (BPE) may have significant negative impact on patients’ health-related quality of life as can certain treatments for the condition. This study aimed to determine the impact of medical therapy on health-related quality of life among patients on treatment for BPO.This was a hospital based descriptive study carried out in urology public and private clinics from April to December 2017. All diagnostic and treatment options of patients were decided by attending clinicians of which Patients aged ≥40 years on medical treatment for BPO were included. Symptom and Health Related Quality Life (HRQL) were measured at baseline and at 3 months using the International Prostate Symptom Score (IPSS) and the Benign Prostatic Hyperplasia Impact Index score (BII) tools. A total 150 patients were included in the analysis with a mean age of 54), mean PSA of 4.45ng/ml and a mean prostate volume 54.62cc. Majority, 144(96.5%) had moderate and severe LUTS and 94(63%) men received a combination of tamsulosin and finasteride and 44(29%) men received tamsulosin alone: Medical therapy was associated with overall improvement of quality of life (p<0.001). A combination of tamsulosin and finasteride was associated with more adverse effects. Improvements in Quality of life (QoL) and symptoms were noted across the medical treatments most widely used in real-life practice at MNH to manage patients with BPO. Tamsulosin showed an equivalent efficacy to a combination of tamsulosin and finasteride at third month of therapy with fewer adverse effects.

scholarly journals The Impact of Trust on the Quality of Participation in Development

2020 ◽  
Vol 10 (2) ◽  
pp. 72-92
Author(s):  
Tadashi Hirai
Keyword(s):  
Adverse Effects ◽  
Everyday Life ◽  
The Political ◽  
Effective Implementation ◽  
Societal Development ◽  
Political Economic ◽  
The Impact

Participation is essential in societal development. Nevertheless, it still tends to be implemented unsystematically, and to be interpreted loosely without attention to context. For effective implementation, trust needs to be taken more seriously. The nexus between participation and trust plays a key role in societal processes toward democracy. Highlighting it is particularly relevant to the political, economic, cultural, and environmental transition in Ukraine, where participation is encouraged while the level of trust is fragile, resulting in multiple adverse effects on everyday life. Accordingly, this article investigates the significance of effectively implementing participation and the impact of trust upon its quality, depicting Ukraine as a counterexample. While participation is vital, it needs to be managed with care, according to the level of trust in society.

Sign in / Sign up

Export Citation Format

Share Document